Hospital 12 de Octubre

Usera, Madrid 28041

2 studies enrolling now · 2 studies all time

What they study most

Advanced Melanoma, Hormone Receptor Positive HER-2 Negative Breast Cancer, Hormone Receptor-positive Breast Cancer, Metastatic Breast Cancer

Studies at this site

• Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer — Recruiting now
• Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. — Recruiting now